Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of StimolIrpinia for Cognitive Rehabilitation After Severe Acquired Brain Injury

NCT07718321 is registered in ClinicalTrials.gov with Alfonso Magliacano as lead sponsor.

NCT NCT07718321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07718321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of StimolIrpinia for Cognitive Rehabilitation After Severe Acquired Brain Injury
Lead sponsor
Alfonso Magliacano
Phase
Not applicable
Overall status
Recruiting
Start date
June 22, 2026
Completion date
August 22, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, cognitive rehabilitation, neurorehabilitation, severe acquired brain injury